, , ,

<<

 >>  ()
Pages:     | 1 |   ...   | 7 | 8 ||

.. ...

-- [ 9 ] --

435. Sajadieh A., Nielsen O.W., Rasmussen V., et al. Ventricular arrhythmias and risk of death and acute myocardial infarction in apparently healthy subjects of age or=55 years. Am J Cardiol. 2006;

97(9):13517.

436. Saliba W., Juratli N., Chung M.K., et al. Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation. J Am Coll Cardiol.

1999;

34:20314.

437. Sanfillipo A.J., Abaskal V.M., Sheehan M., et al. Atrial enlargement as a con sequence of atrial fibrillation. A prospective echocardiographic study. Circulation.

1990;

82:7927.

438. Santangeli P., Di Biase L., Russo A.D., et al. Meta-analysis: Age and Effec tiveness of Prophylactic Implantable Cardioverter-Defibrillators. Ann Intern Med.

2010;

153(9):5929.

439. Santini M., Pandozi C., Colivicchi F., et al. Transoesophageal lowenergy car dioversion of atrial fibrillation. Results with the oesophagealright atrial lead con figuration. Eur Heart J. 2000;

21(10):84855.

440. Sasson C., Rogers M.A.M., Dahl J., et al. Predictors of Survival From Out-of Hospital Cardiac Arrest. Circ Cardiovasc Qual Outcomes. 2010;

3(1):6381.

441. Sairaku A., Nakano Y., Oda N., et al. Prediction of sinus node dysfunction in patients with persistent atrial flutter using the flutter cycle length. Europace.

2012;

14(3):3807.

442. Sauer A.J., Moss A.J., McNitt S., et al. Long QT syndrome in adults. J Am Coll Cardiol. 2007;

49:32937.

443. Sawit S.T., Garcia-Alvarez A., Suri B., et al. Usefulness of Cardiac Computed Tomographic Delayed Contrast Enhancement of the Left Atrial Appendage Before Pulmonary Vein Ablation. The American journal of cardiology. 2012;

109[5]:677 84.

444. Scardi S., Humar F., Pandullo C., Poletti A. Oral clonidine for heart rate control in chronic atrial fibrillation. Lancet. 1993;

341:12112.

445. Schatzkin A., Cupples L.A., Heeren T., et al. Sudden death in the Framingham Heart Study. Differences in incidence and risk factors by sex and coronary dis ease status. Am J Epidemiol. 1984;

120(6):88899.

446. Schmidt H., von der Recke G., Illien S., et al. Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol. 2001;





38(3):77884.

447. Schmitt J., Duray G., Gersh B.J., et al. Atrial fibrillation in acute myocardial in farction: a systematic review of the incidence, clinical features and prognostic im plications. Eur Heart J. 2009;

30(9):103845.

448. Schneider M.P., Hua T.A., Bohm M., et al. Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition: A Meta-Analysis. J Am Coll Cardiol.

2010;

55(21):2299307.

449. Schumacher B., Jung W., Lewalter T., et al. Radiofrequency ablation of atrial flutter due to administration of class IC antiarrhythmic drugs for atrial fibrillation.

Am J Card. 1999;

83:7103.

450. Schwartz G.G., Chaitman B.R., Goldberger J.J., et al. High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic at tack. Am Heart J. 2011;

161[5]:9939.

451. Scirica B.M., Braunwald E., Belardinelli L., et al. Relationship Between Nonsustained Ventricular Tachycardia After NonSTElevation Acute Coronary Syndrome and Sudden Cardiac Death. Circulation. 2010;

122(5):45562.

452. Seidl K., Hauer B., Schwick N.G., et al. Risk of thromboembolic events in pa tients with atrial flutter. Am J Card. 1998;

82:5803.

453. Seidl K., Hauer B., Schwick N.G., et al. Comparison of metoprolol and sotalol in preventing ventricular tachyarrhythmias after the implantation of a cardiovert er/defibrillator. Am J Card. 1998;

82:7448.

454. Seidl K., Rameken M., Drogemuller A., et al. Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocar diography to guide directcurrent cardioversion: Final results of the Ludwigshafen Observational Cardioversion Study. J Am Coll Cardiol. 2002;

39:143642.

455. Sellers M.B., Newby L.K. Atrial fibrillation, anticoagulation, fall risk, and out comes in elderly patients. Am Heart J. 2011;

161[2]:2416.

456. ShihAnn Chen, MingHsiung Hsieh, ChingTai Tai et al. Initiation of Atrial Fi brillation by Ectopic Beats Originating From the Pulmonary Veins. Circulation.

1999;

100:187986.

457. Shah R.U., Freeman J.V., Shilane D., et al. Procedural Complications, Re hospitalizations, and Repeat Procedures After Catheter Ablation for Atrial Fibrilla tion. J Am Coll Cardiol. 2012;

59(2):1439.

458. Shirolkar S.C., Fiuzat M., Becker R.C. Dronedarone and vitamin K antagonists:

a review of drugdrug interactions. Am Heart J. 2010;

160(4):57782.

459. Shlipak M.G., Lyons W.L., Go A.S., et al. Should the Electrocardiogram Be Used to Guide Therapy for Patients With Left BundleBranch Block and Suspect ed Myocardial Infarction? JAMA. 1999;

281:7149.

460. Shlipak M.G., Go A.S., Frederick P.D., et al. Treatment and outcomes of left bundlebranch block patients with myocardial infarction who present without chest pain. J Am Coll Cardiol. 2000;

36:70612.

461. Sim I., McDonald K.M., Lavori P.W., et al. Quantative overview of zandomized trials of amiodarone to prevent sudden cardiac death. Circulation. 1997;





96:2823 9.

462. Singh B.N., Connolly S.J., Crijns H.J.G.M., et al. Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter. N Engl J Med. 2007;

357:98799.

463. Sipahi I., Carrigan T.P., Rowland D.Y., et al. Impact of QRS Duration on Clini cal Event Reduction With Cardiac Resynchronization Therapy: Meta-analysis of Randomized Controlled Trials. Arch Intern Med. 2011;

171(16):145462.

464. Sjoblom J., Ljung L., Frick M., et al. Primary prevention of defibrillator implanta tion after myocardial infarction: clinical practice and compliance to guidelines. Eu ropace. 2012;

14(4):4905.

465. Siu C.W., Pong V., Zhang X., et al. Risk of ischemic stroke after newonset atrial fibrillation in patients with hyperthyroidism. Heart Rhythm. 2009;

6(2):16973.

466. Skanes A.C., Krahn A.D., Yee R., et al. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. J Am Coll Cardiol.

2001;

38:16772.

467. Slavik R.S., Tisdale J.E., Borzak S. Pharmacologic conversion of atrial fibrilla tion: A systematic review of available evidence. Prog Cardiovasc Dis.

2001;

44:12152.

468. Sobocinski P.D., Rooth E.A., Kull V.F., et al. Improved screening for silent atrial fibrillation after ischaemic stroke. Europace. 2012;

14(8):11126.

469. Sorajja D., Nesbitt G.C., Hodge D.O., et al. Syncope While Driving: Clinical Characteristics, Causes, and Prognosis. Circulation. 2009;

120(11):928934.

470. Soteriades E.S., Evans J.C., Larson M.G., et al. Incidence and Prognosis of Syncope. N Engl J Med. 2002;

347:87885.

471. Southworth M.R., Zarembski D., Viana M.,et al. Comparison of sotalol versus quinidine for maintenance of normal sinus rhythm in patients with chronic atrial fi brillation. Am J Card. 1999;

83:162932.

472. Stec S.M., Grabczak E.M., Bielicki P., et al. Diagnosis and Management of Premature Ventricular ComplexesAssociated Chronic Cough. Chest.

2009;

135(6):153541.

473. Steinbeck G, Andresen D, Seidl K, et al. Defibrillator Implantation Early after Myocardial Infarction. N Engl J Med. 2009;

361(15):142736.

474. Stellbrink C et al. Safety and Efficacy of Enoxaparin Compared With Unfrac tionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation. Circulation.

2004;

109:9971003.

475. Stenestrand U., Lindback J., Wallentin L., et al. Anticoagulation Therapy in Atrial Fibrillation in Combination With Acute Myocardial Infarction Influences LongTerm Outcome: A Prospective Cohort Study From the RIKSHIA. Circula tion. 2005;

112:322531.

476. Strickberger S.A.,Man K.C.,Daoud E.G., et al. AdenosineInduced Atrial Ar rhythmia: A Prospective Analysis. Ann Intern Med. 1997;

127:41722.

477. Strickberger S.A., Ip J., Saksena S., et al. Relationship between atrial tach yarrhythmias and symptoms. Heart Rhythm. 2005;

2(2):12531.

478. Strote J.A., Maynard C., Olsufka M., et al. Comparison of Role of Early to Later or No Cardiac Catheterization After Resuscitation From Out-of-Hospital Cardiac Arrest. Am J Cardiol. 2012;

109[4]:4514.

479. Sullivan J.M., Ramanathan K.B. Management of medical problems in pregnan cy severe heart disease. N Engl J Med. 1985;

313:3049.

480. Supple G.E., Ren J.F., Zado E.S., et al. Mobile Thrombus on Device Leads in Patients Undergoing Ablation. Circulation. 2011;

124(7):7728.

481. Surawicz B. Transient T wave abnormalities after cessation of ventricular preexcitation: memory of what? J Cardiovasc Electrophysiol. 1996;

7(1):519.

482. Swindle J.P., Rich M.W., McCann P., et al. Implantable Cardiac Device Proce dures in Older Patients: Use and InHospital Outcomes. Arch Intern Med.

2010;

170(7):6317.

483. Swiryn S. RATE registry: Longer bouts of atrial arrhythmia have worse out comes. American Heart Association 2012 Scientific Sessions.

http://www.theheart.org/article/1475603.do.

484. Sy R.W., van der Werf C., Chattha I.S., et al. Derivation and Validation of a Simple Exercise-Based Algorithm for Prediction of Genetic Testing in Relatives of LQTS Probands. Circulation. 2011;

124(20):218794.

485. Schwartz P.J., Moss A.J., Vincent G.M., Crampton R.S. Diagnostic criteria for the long QT syndrome. An update. Circulation. 1993;

88:7824.

486. Taggart N.W., Haglund C.M., Tester D.J., et al. Diagnostic miscues in congeni tal longQT syndrome. Circulation. 2007;

115:261320.

487. Task Force on Sudden Cardiac Death of the European Society of Cardiology.

Eur Heart J. 2001;

22:1374450.

488. Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA. 1993;

270:158995.

489. Terasawa T., Balk E.M., Chung M., et al. Systematic Review: Comparative Ef fectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation. Ann Intern Med. 2009;

151(3):191202.

490. Toff W.D., Camm A.J., Skehan J.D., the United Kingdom Pacing and Cardio vascular Events (UKPACE) Trial Investigators. SingleChamber versus Dual Chamber Pacing for HighGrade Atrioventricular Block. N Engl J Med.

2005;

353(2):14555.

491. Trivalle C., Doucet J., Chassagne P., et al. Differences in the signs and symp toms of hyperthyroidism in older and younger patients. J Am Geriatr Soc. 1996;

(1):50 492. Tzivoni D., Keren A. Supression of ventricular arrhythmias by magnesium. Am J Card. 1990;

65:13979.

493. Update of guidelines on sudden cardiac death of European Society of Cardiol ogy. Eur Heart J. 2003;

24:135.

494. Van Gelder I.C., Crijns H.J., Tieleman R.G., et al. Chronic atrial fibrillation:

success of serial cardioversion therapy and safety of oral anticoagulation. Arch In tern Med. 1996;

156:258592.

495. Van Gelder I.C., Groenveld H.F., Crijns H.J.G.M., et al. Lenient versus Strict Rate Control in Patients with Atrial Fibrillation. N Engl J Med. 2010;

362(15):1363 73.

496. Van Gelder I.C., Haegeli L.M., Brandes A., et al. Rationale and current perspective for early rhythm control therapy in atrial fibrillation. Europace.

2011;

13(11):151725.

497. Van Noord T., Van Gelder I.C., Crijns H.J. How to enhance acute outcome of electrical cardioversion by drug therapy: importance of immediate reinitiation of atrial fibrillation. J Cardiovasc Electrophysiol. 2002;

13(8):8225.

498. van Rees J.B., de Bie M.K., Thijssen J., et al. Implantation-Related Complica tions of Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy Devices: A Systematic Review of Randomized Clinical Trials. J Am Coll Cardiol. 2011;

58(10):9951000.

499. van Rees J.B., Willem Borleffs C.J., Thijssen J., et al. Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, survival gain. Europace. 2012;

14(1):6673.

500. Vega F., Mehta M., Young M.L. Successful Radiofrequency Catheter Ablation of a Chaotic Atrial Tachycardia. HeartWeb. 1999;

4(9).

501. Vidal E., Tom H., Robert W.P., et al. Amiodarone and the risk of bradyarrhyth mia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol. 2003;

41:24954.

502. Viles-Gonzalez J.F., Kar S., Douglas P., et al. The Clinical Impact of Incom plete Left Atrial Appendage Closure With the Watchman Device in Patients With Atrial Fibrillation: A PROTECT AF Substudy. J Am Coll Cardiol. 2012;

59(10):923 9.

503. Viskin S. The QT interval: too long, too short or just right. Heart Rhythm.

2009;

6(5):7115.

504. Volgman A.S., Carberry P.A., Stambler B., et al. Conversion Efficacy and Safe ty of Intravenous Ibutilide Compared With Intravenous Procainamide in Patients With Atrial Flutter or Fibrillation. J Am Coll Cardiol. 1998;

31:14149.

505. Volpi A., Cavalli A., Turato R., et al. Incidence and shortterm prognosis of late sustained ventricular tachycardia after myocardial infarction: results of the GISSI 3 Data Base. Am Heart J. 2001;

142:8792.

506. Waldo A.L., Prystowsky E.N. Drug Treatment of Atrial Fibrillation in the Man aged Care Era. Am J Card. 1998;

81:23C9C.

507. Wallentin L., Yusuf S., Ezekowitz M.D., et al. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation. The Lancet. 2010;

376:97583.

508. Wazni O.M., Marrouche N.F., Martin D.O., et al. Radiofrequency ablation vs antiarrhythmic drugs as firstline treatment of symptomatic atrial fibrillation: a ran domized trial. JAMA. 2005;

293:263440.

509. Weber B.E., Kapoor W.N. Evaluation and outcomes of patients with palpita tions. Am J Med. 1996;

100:13848.

510. Weerasooriya R., Davis M., Powell A., et al. The Australian intervention ran domized control of rate in atrial fibrillation trial (AIRCRAFT). J Am Coll Cardiol.

2003;

41:1697702.

511. Wellens H.J.J., Brugada P., Heddle W.F. The value of the 12lead ECG in di agnosing and mechanism of a tachycardia: a servey among 22 cardiologists. J Am Coll Cardiol. 1984;

4:1769.

512. Wellens H.J., ChuPak Lau, Luderitz B., et al. Atrioverter: An Implantable De vice for the Treatment of Atrial Fibrillation. Circulation. 1998;

98:16516.

513. Wellens H.J. Pulmonary vein ablation in atrial fibrillation: hype or hope? Circu lation. 2000;

102:25624.

514. Welles C.C., Whooley M.A., Na B., et al. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart dis ease: Data from the Heart and Soul Study. Am Heart J. 2011;

162[3]:55561.

515. Weerasooriya R., Khairy P., Litalien J., et al. Catheter Ablation for Atrial Fibril lation: Are Results Maintained at 5 Years of FollowUp? J Am Coll Cardiol.

2011;

57(2):1606.

516. Widerhorn J., Widerhorn A.L.M., Rahimtoola S.H., Elkayam U. WPW syn drome during pregnancy: Increased incidence of supraventricular arrhythmias. Am Heart J. 1992;

124:796.

517. Wijnmaalen A.P., Schalij M.J., von der Thusen J.H., et al. Early Reperfusion During Acute Myocardial Infarction Affects Ventricular Tachycardia Characteristics and the Chronic Electroanatomic and Histological Substrate. Circulation 2010;

121(17):188795.

518. Wilber D.J., Pappone C., Neuzil P., et al. Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled Trial. JAMA. 2010;

303(4):33340.

519. Winkle R.A., Mead R.H., Engel G., et al. Relation of Early Termination of Per sistent Atrial Fibrillation by Cardioversion or Drugs to Ablation Outcomes. Am J Cardiol. 2011;

108[3]:3749.

520. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;

22:9838.

521. Wolk R., Kulakowski P., Karczmarewicz S., et al. The incidence of asympto matic paroxysmal atrial fibrillation in patients treated with propranolol or propafenone. Int J Cardiol. 1996, 54:20711.

522. Wood M.A., Curtis A.B., TakleNewhouse T.A., et al. Survival of DDD Pacing Mode After Atrioventricular Junction Ablation and Pacing for Refractory Atrial Fi brillation. Am Heart J. 1999;

137(4):6825.

523. Wren C., Campbell R.W., Hunter S. Role of echocardiography in differential di agnosis of broad complex tachycardia. Br Heart J. 1985;

54(2):16672.

524. Wyse D.G., Friedman P.L., Brodsky M.A., et al. Lifethreatening ventricular ar rhythmias due to transient or correctable causes: high risk for death in followup.

J Am Coll Cardiol. 2001;

38:171824.

525. Yamabe H., Shimasaki Y., Honda O., et al. Demonstration of the Exact Ana tomic Tachycardia Circuit in the FastSlow Form of Atrioventricular Nodal Reen trant Tachycardia. Circulation. 2001;

104:1268.

526. Yang F., Hanon S., Lam P., Schweitzer P. Quinidine revisited. Am J Med.

2009;

122(4):31721.

527. Yu C.M., Chan J.Y.S., Zhang Q., et al. Biventricular Pacing in Patients with Bradycardia and Normal Ejection Fraction. N Engl J Med. 2009;

361(22):212334.

528. Zardini M., Yee R., Thakur R. K., et al. Risk of sudden arrhythmic death in the WolffParkinsonWhite syndrome: Current perspectives. PACE. 1994;

17:966.

529. Zareba W., Moss A.J., Schwartz P.J., et al. Influence of genotype on the clini cal course of the longQT syndrome: International LongQT Syndrome Registry Research Group. N Engl J Med. 1998;

339:96065.

530. Zheng Z.J., Croft J.B., Giles W.H., Mensah G.A. Sudden Cardiac Death in the United States, 1989 to 1998. Circulation. 2001;

104:2158.

531. Ziegler P.D., Glotzer T.V., Daoud E.G., et al. Detection of Previously Undiag nosed Atrial Fibrillation in Patients With Stroke Risk Factors and Usefulness of Continuous Monitoring in Primary Stroke Prevention. Am J Card.

2012;

110[9]:130913.



Pages:     | 1 |   ...   | 7 | 8 ||
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .